title: Low-molecular-weight heparins: are they all the same?
authors.affiliation: Division of General Medicine, University of California-Davis, 4150 V Street, Sacramento, CA 95817, USA. rhwhite@ucdavis.edu
authors.forename: Richard H
authors.initials: RH
authors.lastname: White
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Ginsberg
mesh_terms: D000789:Angina, Unstable / Q000188:drug therapy; D001780:Blood Coagulation Tests; D017985:Dalteparin / Q000494:pharmacology / Q000627:therapeutic use; D017984:Enoxaparin / Q000494:pharmacology / Q000627:therapeutic use; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control; D000078222:Tinzaparin; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin; D017985:Dalteparin